6
Oct
2026

Egis Pharmaceuticals PLC

Exhibitor at CPHI Milan 2026 stand 7D74, Integrated Pharma
About Us

Egis is a leading Hungarian generic pharmaceutical company with over 110 years of experience. In 2023/2024 financial year, Egis Group generated net sales of nearly EUR 693 million. We cover the full value chain—from R&D and API/FP manufacturing to marketing in 60+ countries. At Egis, besides simple generics, we deliver value-added generic and highly potent products through advanced chemistry, streamlined production, and strong IP expertise. Our portfolio includes 653 products focused on cardiovascular, CNS, diabetes, dermatology, oncology and wound care.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Hungary
  • On CPHI since:
    2015
  • Employees:
    1000 - 4999
Company types
Manufacturer/Innovator
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 7D74, Integrated Pharma

Products Featured at CPHI Milan 2026

  • Active Ingredients

    Product Active Ingredients

    Egis Pharmaceuticals PLC provides a wide range of products which includes active pharmaceutical ingredients. Contact us for more information.
  • Finished Products

    Product Finished Products

    Egis Pharmaceuticals PLC provides a wide range of products which includes finished products. Contact us for more information.
  • For patients

    Product For patients

    Egis Pharmaceuticals PLC provides a range of OTC products for patients. Contact us for more information.